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Abstract A new member of the staphylococcal bi-component
leucotoxins family, LukE (32 kDa) and LukD (34.3 kDa) has
been characterized from Staphylococcus aureus strain Newman.
LukE was 58^68% identical with the class S proteins, whereas
LukD was 71^77% identical with the class F proteins of the
family. A partial immunoreactivity with the various affinity-
purified antibodies specific for the other proteins was observed.
Immunoprecipitation assay and gene probing confirmed a 30%
frequency among human clinical isolates, differing from the
distribution of the other known leucotoxins (P6 0.005).
LukE+LukD was as effective as the Panton-Valentine leucocidin
for inducing dermonecrosis when injected in the rabbit skin, but
not hemolytic and poorly leucotoxic compared to other
leucotoxins expressed by Staphylococcus aureus.
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1. Introduction
Staphylococcal bi-component leucotoxins are composed of
two distinct proteins: S-related (Slow eluted: 31^32 kDa) or
F-related proteins (Fast eluted: 36^38 kDa) that are secreted
separately, but act synergistically upon human polymorpho-
nuclear cells or erythrocytes (PMNs). They constitute a family
of pore-forming toxins comprising the anciently described
Panton-Valentine leucocidin (PVL = LukS-PV+LukF-PV)
[29], and Q-hemolysin, self-comprising two leucotoxic entities
HlgA+HlgB and HlgC+HlgB where HlgA and HlgC are S-
related components and HlgB is an F-related component
[6,22]. The previous leucocidin R and that encoded by a me-
thicillin-resistant S. aureus are bi-component leucotoxins com-
parable to the latter [13,22,28]. Recently, another S-related
protein, LukM, which is also coupled to a class F component,
LukF-PV like (LukFP-PV in this text), was characterized [14].
Another leucotoxin, LukS-I+LukF-I was reported to be pro-
duced by Staphylococcus intermedius strains [23]. These com-
ponents were shown to be predominantly constituted of L-
sheet structures [20]. Genes encoding PVL are distributed in
2% of clinical strains, strongly associated with furuncles [7,21].
Q-Hemolysin encoding genes are encountered in 99% of clin-
ical isolates of S. aureus [21]. Any combination of a given
class S protein with a class F protein may be toxic [22] and
generates an intense in£ammatory response when injected in
the rabbit skin [8] or in the pars plana of the rabbit eye [25].
Sequential binding of S components to cell membranes is a
prerequisite for that of F components [5]. This provokes a
Ca2 in£ux by opening of Ca2 channels [27], and the activa-
tion of target cells [15,16]. Then, the leucotoxin forms pores
through the plasma membrane which are sensitive to both
Na, K, or ethidium [10,19,27].
The aim of this work was to characterize a cross-immuno-
reactive product with PVL components, and to demonstrate
its e¡ective membership in this leucotoxin family.
2. Materials and methods
2.1. Bacteria and animals
Escherichia coli XL1 Blue (Stratagene) was used as a recipient strain
of the reduced genomic library cloned into the shuttle plasmid (E. coli/
S. aureus) pCU1 [2], kindly given by F. Goºtz (Tuºbingen, Germany). S.
aureus Newman (NTCC 8178) and P83 strains were used for the
puri¢cation of LukE/LukD and LukM/LukFP-PV [14], respectively.
For the toxin-production study, 127 consecutive clinical strains from
127 individuals were collected from the routine laboratory of the
Strasbourg University Hospital.
2.2. Protein puri¢cation
One colony of Newman strain was grown for 8 h in 5 ml of YCP
(3% (w/v) yeast extract (Oxoid), 2% (w/v) bacto-casaminoacids (Dif-
co), 2% (w/v) sodium pyruvate (Merck), 0.25% (w/v) Na2HPO4,
0.042% (w/v) KH2PO4, pH 7.0) at 37‡C. Then, the puri¢cation pro-
cedure was as described earlier [9,27], involving MonoS cation-ex-
change FPLC (Fast Performance Liquid Chromatography, Pharma-
cia, Uppsala, Sweden) and AlkylSuperose hydrophobic FPLC,
respectively. Puri¢ed compounds were controlled by SDS-PAGE elec-
trophoresis on PHAST System (Pharmacia) and then stored at 380‡C
at OD280nm = 1.0 in 50 mM Na-phosphate bu¡er, 150 mM NaCl, pH
7.0.
2.3. Nucleic acids methods
DNA modifying and restriction enzymes were used as recom-
mended by the manufacturers (New England Biolabs-Gibco-BRL).
A synthetic 5P 32P-labelled oligonucleotide 5P-GAAAATATA/
TGGA/TGATGGA/TGCA/TGAAGTTAT-3P whose sequence was
deduced from the N-terminal sequence of LukE: NTNIENIGDGAE-
VIKRTE was used as a probe for cloning lukE and lukD. A total
DNA [28] library of Newman strain reduced to HindIII DNA frag-
ments ranging from 2.0 to 3.0 kb inserted into pCU1 was screened as
previously described [23]. Universal and reverse primers and the clon-
ing oligonucleotide were initially used for nucleotide sequence deter-
mination of double stranded DNA with T7 DNA polymerase [24].
Other primers were deduced from the previously read sequences. To-
tal RNA from 1 ml of 10-, 13-, and 16-h cultures of Newman strain
was prepared by the Fast Prep (Bio101) method [4]. Southern and
Northern blots [24] were performed by using QIABRANE membrane
(Qiagen, Paris). For the determination of the transcription start of
lukE-lukD, total RNA of Newman strain was submitted to extension
with the 5P 32P-labelled oligonucleotide 5P-552-TCCTACTGCAAAC-
TTGCAGCTAACA-3P-527. The reaction was carried out with 5 Wg of
RNA with a 1-h hybridization step at 65‡C and a 45-min primer
extension with an avian myeloblastosis virus reverse transcriptase
(Appligene) as previously described [18]. DNA and peptide analyses
were performed with DNAStar software (DNAStar, London, UK).
The nucleotide sequence of lukE/lukD is recorded at the EMBL/Gen-
Bank library with the accession number Y13225.
FEBS 20890 5-10-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 1 1 3 0 - 2
*Corresponding author. Fax: (33) (3) 88 25 11 13.
E-mail: gprevibs@tpgnet.net
FEBS 20890FEBS Letters 436 (1998) 202^208
2.4. Anti-LukE, -LukD, and -LukM antibodies and radial gel
immunoprecipitations
Anti-LukS-PV and anti-LukF-PV a⁄nity-puri¢ed rabbit polyclonal
antibodies [9] were used for immunoblotting [24] during the puri¢ca-
tion of LukE and LukD. The rabbit polyclonal antibodies anti-LukE,
anti-LukD and anti-LukM were a⁄nity-puri¢ed [9]. All available anti-
bodies were used in immunoprecipitation assays [9] for the detection
of the production of PVL, LukE+LukD, and LukM+LukFP-PV by
clinical isolates. A fresh colony of each strain was incubated in a 24-
well cell culture plate ¢lled with 550 Wl of YCP medium, for 16 h at
37‡C under a 10% CO2 humid atmosphere with 180 rpm rotary shak-
ing. To enhance the detection, immunoprecipitation plates were capil-
lary dried. Proteins were precipitated for 5 min in 5% (w/v) trichloro-
acetic acid, and stained with 0.1% (w/v) Coomassie blue for 15 min,
then washed ¢ve times with a 10% (v/v) acetic acid/30% (v/v) meth-
anol solution, and ¢xed with a 10% (v/v) acetic acid/5% (v/v) glycerol
solution. The M2 test was used to compare the di¡erent distributions
of the leucotoxin-producing strains.
2.5. Preparation of human polymorphonuclear cells (PMNs)
Twelve ml of J-Prep solution (TechGen) were added to 30 ml of
bu¡y coats from healthy donors and human PMNs were prepared as
previously described [27]. Human PMNs were suspended and adjusted
to 2U106 cells/ml with 140 mM NaCl, 5 mM KCl, 10 mM glucose,
0.1 mM ethylene glycol-bis-(L-aminoethyl ether) N,N,NP,NP-tetraace-
tic acid, 10 mM HEPES, 3 mM Tris-base (pH 7.3). The latter bu¡er
was used to wash, after loading the cells with the Ca2-speci¢c £uo-
rescent probe Fluo-3 (Molecular Probes, Eugene, OR, USA).
2.6. Flow cytometry measurements
Assays were made with 2U106 cells/ml loaded with 5 WM Fluo-3
during 1 h at 37‡C, then washed and resuspended in the absence or
presence of 1 mM free Ca2, and 25 nM ethidium bromide. Proteins
were added at 2 nM. Flow cytometry measurements were performed
by using a FacSort (Becton-Dickinson, Le Pont de Claix, France)
equipped with a 15-mW argon laser tuned at 488 nm. Forward
(FSC) and Side (SSC) light scatter dot plots acquired from 5000
leucocytes (2U106 cells/ml) were classically gated [19]. Fluo-3 £uores-
cence due to the calcium penetration through opening of Ca2 chan-
nels was recorded from the £uorescence light 1 (VEm = 530 nm). The
£uorescence light 3 (VEm = 650 nm) was used to record the £uorescence
of ethidium combined with nucleic acids, after penetrating through
the leucotoxin pores. Data were calculated by Lysis 2TM software
(Becton-Dickinson, France) and results expressed as mean þ S.D. of
data obtained from PMNs of four di¡erent donors, at least.
2.7. Activity of LukE, LukD in a rabbit skin model
Shaved New Zealand rabbits (v2.5) were injected intradermally
with 50 Wl of sterile 9.55x (w/v) PBS Dulbecco solution with equal
amounts (100, 300, 1000, 3000, 10 000 ng) of class S- and class F-
related components [8,22]. Clinical observations were recorded 12, 24,
and 48 h after injection of toxins. Five reaction levels re£ecting the
intensity of the lesions were de¢ned according to the evolution of the
in£ammatory response: level 0 was the normal skin, level 1 showed a
red in£ammatory reaction (q= 10^15 mm) without abscess forma-
tion, level 2 showed a hot, red papule with relief (q= 15^20 mm,
5 mm high), level 3 showed a more intense, blue and oedematous
abscess (q= 20^30 mm, 10 mm high), level 4 still progressed
(q= 30 mm, 10^15 mm high) with pus collection surrounded by
blue oedema, level 5 showed a lesion with a central depression and
pus sweating. Data obtained from three independent series of injec-
tions were analyzed with the non-parametric test of Wilcoxon-Mann-
Whitney.
3. Results
3.1. New leucotoxin characterization
Characterization of a new leucotoxin from S. aureus strain
Newman originated by the observation in culture supernates
(Fig. 1A) of materials immunologically related to HlgC,
LukS-PV, LukF-PV, but not with HlgA, HlgB and LukM,
when the strain was grown in YCP medium. This observation
evidenced that the supernatants contained proteins related to
class S and class F components, which di¡ered from PVL,
Q-hemolysin or LukM/LukFP-PV. However, the Newman
strain grown in HI medium then produced detectable amounts
of HlgA, HlgB, and HlgC (Fig. 1A). By using the radial gel
immunoprecipitation test, the class S protein arbitrarily called
LukE and the class F protein called LukD were puri¢ed by
using previously described chromatographies. The class S-re-
lated LukE protein was eluted on MonoS at a NaCl concen-
tration of 280^290 mM similar to that of LukM. However,
LukE was eluted in 1 M (NH4)2SO4 by hydrophobic chroma-
tography whereas LukM was not retained. LukD and LukF-
PV were eluted at 110 mM NaCl onto MonoS and at 780 mM
(NH4)2SO4 onto alkyl-Superose. LukD and LukF-PV were
produced by di¡erent strains. SDS-PAGE analysis of puri¢ed
LukE and LukD con¢rmed apparent molecular masses similar
to the other class S proteins (32 kDa) and to the other class F
proteins (36 kDa), respectively (data not shown).
A⁄nity-puri¢ed antibodies were speci¢c enough to distin-
guish amongst the related antigens (Fig. 1B), by generating
continuous immunoprecipitation lines only with correspond-
ing proteins and crossed immunoprecipitation lines between
heterologous proteins. Few proteins were not precipitated by
antibodies like LukE, LukS-PV and LukM by anti-HlgA anti-
bodies, HlgC by anti-LukE antibodies, HlgA and LukM by
anti-HlgC antibodies, or HlgA and LukS-PV by anti-LukM
antibodies (Fig. 1B). Antigenic similarity seemed closer with
LukD, HlgB, LukF-PV, LukFP-PV; LukFP-PV was not pre-
cipitated by anti-HlgB antibodies.
3.2. Cloning and sequencing lukE and lukD
Hybridization of the total DNA from Newman strain with
the new leucotoxin-directed oligonucleotide probe (data not
shown) revealed DraI (2.1 kb), EcoRI (9 kb), EcoRV (s 10
kb), HincII (1.9 kb), HindIII (2.8 kb), PstI (s 10 kb), ScaI
(2.1 kb) DNA fragments di¡ering in length from the EcoRI
(s 8.3 kb), EcoRV (4.2 kb), ScaI (3.8 kb) DNA fragments
speci¢c of the hlg locus, which seemed to be highly conserved
in a majority of S. aureus isolates [21,22].
A clone containing a 2.8-kb HindIII insert was obtained
and immunoblotting of the crude extract of the recombinant
E. coli strain indicated the production of both LukE and
LukD with apparent molecular masses comparable to those
of the puri¢ed components (data not shown). Sequence anal-
ysis of a 2571-bp long nucleotide sequence overlapped two
consecutive ORFs (Fig. 2) which spanned positions 511^
1455 and 1457^2440, respectively. No open reading frame
was found in the 500-bp preceding lukE di¡ering from the
Q-hemolysin locus. The two ORFs are separated by one thy-
midine as in other related genes (Fig. 2), and cotranscribed in
a single mRNA expressed at the late exponential growth (Fig.
3A). Predictable 335 and 310 transcription signals and a
putative ribosome binding site are reported in Fig. 2. The
determination of the transcription start by the primer exten-
sion method (Fig. 3B) indicated the nucleotide 477, located 10
bases downstream the 335 box. lukE encodes a 314-amino
acid protein with a calculated molecular mass of 35 222 Da
and a calculated pI of 9.87. The sequence encoding a peptide
NTNIEN..., located 28 amino acids dowstream the ATG ini-
tiation codon, corresponds exactly to the N-terminal sequence
of LukE. This 28-residues long peptide bearing positively-
charged residues followed by hydrophobic amino acids corre-
sponds to the secretion signal peptide. The secreted 286-amino
FEBS 20890 5-10-98
A. Gravet et al./FEBS Letters 436 (1998) 202^208 203
acid LukE has a calculated molecular mass of 32 239 Da and
a calculated pI of 9.88. Amino acid content of the secreted
LukE revealed twice more basic than acidic residues (42:23).
LukE had from 58.7% to 68% identity with the other class S
components [6,14,22], with no conserved peptide sequence
longer than 7 residues.
The second ORF, lukD, encodes a 327-amino acid-long
protein with a calculated molecular mass of 36 974 Da and
a calculated pI of 9.09. This nucleotide sequence is preceded
by an rbs-like sequence. An inverted repeat probably involved
in the termination of the transcription is located 60 bp down-
stream the stop codon of lukD. The 18 ¢rst sequenced N-
terminal residues of the secreted LukD (AQNIT...), corre-
spond to those deduced from the nucleotide sequence (posi-
tion 1535). Therefore, the signal peptide of LukD, bears sim-
ilar characteristics as above, contains 26 residues, and the
secreted LukD is 301 amino acids long for a calculated mo-
lecular mass of 34 302 Da with a calculated pI of 9.02. The
peptide sequence identity of LukD with class F components
was comprised between 71 and 77% according to the proteins.
Four domains were conserved between LukD and other class
F components (from residues 34 to 52, 94 to 103, 137 to
150, 166 to 183). Despite a lack of sequence identity with
K-toxin [12], homology was observed with both class S and
class F proteins, con¢rming the observations described
recently [11].
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Fig. 1. Characterization of the new staphylococcal leucotoxin LukE/LukD. Panel A: Identi¢cation of materials immunologically related to bi-
component leucotoxins secreted by S. aureus Newman strain. Immunoprecipitation tests of culture supernatants (s) in YCP and HI media
against 100 Wg of a⁄nity-puri¢ed rabbit antibodies anti-HlgA (CA), anti-HlgB (CB), anti-HlgC (CC), anti-LukF-PV (CF), anti-LukM
(CM), anti-LukS-PV (CS) a⁄nity puri¢ed rabbit polyclonal antibodies and 1 Wg of HlgA (A), HlgB (B), HlgC (C), LukF-PV (F), LukM
(M), LukS-PV (S). Panel B: Analysis by an immunoprecipitation assay stained with Coomassie blue of the antigenic relations between 1 Wg of
puri¢ed proteins constituting leucotoxins (HlgA: A; HlgB: B; HlgC: C; LukD: D; LukE: E; LukF-PV: F; LukM: M; LukS-PV: S), and
100 Wg of the corresponding a⁄nity-puri¢ed rabbit antibodies (CA, CB,...).
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3.3. LukE+LukD and LukM production in 127 S. aureus
clinical isolates
For the study of the production of LukE+LukD among
clinical isolates, attention was given to obtain signi¢cant series
of isolates for each kind of sample. The immunoprecipitation
test revealed no isolate producing LukM. Only one produced
the PVL, which is in agreement with the previously described
results [7,21]. However, 40 isolates (31.5%) produced LukE+
LukD. This was con¢rmed by hybridization of HindIII-re-
stricted DNAs with the lukE-oligonucleotide probe used for
the mRNA mapping (data not shown). The hybridized DNA
fragments were 3.1 and s 8.3 kb long, according to the
strains. No positive isolate was found among urine-originated
samples, whereas a similar distribution concerned respiratory
(6:29), skin samples (9:31), infected materials (8:19) and
blood cultures (4:19). Most of the LukE+LukD-producing
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Fig. 2. Nucleotide sequence (EMBL/GenBank Y13225) of lukE (positions 511^1455) followed by that of lukD (positions 1457^2440) and the de-
duced peptide sequences from S. aureus Newman strain. The stop codon of lukE is located 1 base upstream the ATG codon of lukD. Signal
peptides of the two proteins LukE and LukD are underlined. Putative consensus sequences (i.e. ribosome binding site (rbs) and promotor se-
quences 335 and 310) and the start point of the messenger RNA are mentioned. An inverted repeat sequence probably used as a transcription
terminator (positions 2500^2521) is indicated by arrows.
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strains were isolated as pure cultures from diarrhea (77%) and
were methicillin-resistant strains.
3.4. Biological activity
Such strains as Newman produce two leucotoxins among Q-
hemolysin, PVL, and LukE+LukD. Class S-class F protein
combinations were tested in hemolytic assays on rabbit
(RRBC) and human (HRBC) red blood cells [22], on human
PMNs and in a dermonecrosis assay in rabbit skin. None of
the leucotoxin proteins alone induces any biological activity
which excluded that they were contaminated. Neither LukE
when combined with one of the class S components (i.e.
LukS-PV, HlgA, HlgC, LukM), nor LukD combined with
one of the class F components (i.e. LukF-PV, HlgB, LukFP-
PV) harbored any biological activity.
3.4.1. In vitro assays. On HRBC, only the speci¢c activ-
ities of LukE+HlgB = 7U102 þ 0.5U102, HlgA+LukD = 103 þ
0.5U102 and HlgA+LukFP-PV = 104 þ 2U103 U/mg were
quanti¢able but largely smaller than that of HlgA+HlgB
(5U107 þ 2U106 U/mg). On RRBC, the speci¢c activities of
HlgA+LukD = 3U105 þ 104, and HlgA+LukFP-PV = 3U106
þ 105 were signi¢cant, whereas the other LukE-, LukD-,
LukM-, LukFP-PV-derived combinations remained basal com-
pared to other leucotoxins [22].
The in£ux of Ca2 in human PMNs provoked by the pri-
mary opening of Ca2 channels [27] consecutive to leucotoxin
activity was tested in the presence of 1 mM free Ca2 for the
20 class S/class F protein combinations. The most potent
couple HlgA+HlgB was assumed at 1000 arbitrary units of
Fluo3-£uorescence from loaded PMNs and was compared
with £uorescence intensities obtained with other pairs (Table
1). Cells were not lysed and the remaining lymphocytes were
not susceptible to them. According to the calculated S.D.
values, two kinds of results were obtained: (i) those presenting
an S.D. value lower than the mean of assays; and (ii) those
with a higher S.D. The ¢rst kind of results corresponded to
pairs which were active with all the tested donors. HlgA was
active in combination with all the F components, but the
HlgA+LukD pair was the only combination with LukD pre-
senting an activity. HlgA+LukFP-PV and LukS-PV+LukF-PV
were as potent as HlgA+HlgB. HlgC was as active with HlgB
as with LukFP-PV but less active with LukF-PV and LukD.
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Fig. 3. Cotranscription of lukE and lukD, and determination of the corresponding mRNA start. A: Northern blot analysis of the total RNAs
from S. aureus ATCC 49775 and Newman strains (YCP medium) with the labelled lukE/lukD genes. Lane 1: Total RNA from 108 CFU of
ATCC 49775 after 12 h of culture. Lanes 2, 3, 4: Total RNA from 108 CFU of Newman after 12, 9, 6 h of culture, respectively. Lengths of
the 16 s (1540 bases) and the 23 s (2904 bases) RNAs from S. aureus were obtained from formaldehyde-agarose gel stained with ethidium bro-
mide. B: Primer extension indicated nucleotide A477 (T on the coding strand) as the mRNA start of lukE/lukD. Lanes A, C, G, T: Sequencing
reactions; lane R, primer extension.
Table 1
Biological activities of the 20 possible leucotoxin combinations in S. aureus on the opening of Ca2 channels of human PMNS
Components HlgB LukD LukF-PV LukFP-PV
HlgA 1000 349 þ 138 664 þ 163 907 þ 108
HlgC 497 þ 288 130 þ 245 183 þ 177 493 þ 246
LukS-PV 504 þ 242 100 þ 186 972 þ 183 672 þ 207
LukM 167 þ 180 99 þ 166 276 þ 197 295 þ 198
LukE 310 þ 277 90 þ 167 136 þ 211 166 þ 221
Data were obtained from the analysis of 5000 puri¢ed cells, previously charged with Fluo-3. The most lytic couple HlgA+HlgB was referred as 1000
arbitrary £uorescence units. Data are the mean þ S.D. of 4 independent experiments.
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LukM presented the same activity with LukFP-PV or with
LukF-PV. LukE+HlgB was representative of the second
kind of results where leucotoxins appeared randomly active
according to the donor. For a series of four donors, only one
possessed PMNs more or less sensitive to these pairs. In the
absence of Ca2, pore formation was studied by the entry of
ethidium (Fig. 4). HlgA was the only S component presenting
a little activity with LukD and all other class F components.
LukFP-PV was the only class F component presenting activity
with all class S proteins, although weak with LukE and
LukM. LukFP-PV was the most potent F component with
HlgC and with LukS-PV. The high S.D. value obtained for
HlgC+LukFP-PV, particularly after a 30-min incubation, was
due to variability of the lag-time preceding pore formation,
according to the donor. In the presence of calcium, only few
combinations as HlgA+HlgB or LukS-PV+LukF-PV formed
pores and couples including LukE, LukM and LukD were
devoid of activity (data not shown, [29]).
3.4.2. In vivo assays. Intradermal injections of leucotoxins
in rabbit skin involving LukE, LukD and LukM, or LukFP-
PV may induce a dermonecrotic reaction, according to the
combinations. No variation was observed for rabbits receiving
the same doses of leucotoxins (P6 0.05). Table 2 indicates
that LukE+LukD was as potent as PVL, but the couples
LukE+LukF-PV, LukM+LukD, LukE+LukF-PV, LukS-
PV+LukD, HlgA+LukD, HlgC+LukD led to dermonecrotic
lesions according to the doses and the delay after injections.
Pairs containing HlgB, i.e. LukE+HlgB and LukM+HlgB
were signi¢cantly less e¡ective with no pus collection whatever
the dose and the time following injections (P6 0.05). The
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Fig. 4. The pore formation by the leucotoxins, in the absence of 1 mM Ca2 out of human PMNs, was recorded by the entry of ethidium in
5000 puri¢ed cells, previously charged with Fluo-3. Data were obtained on FacSort (Becton-Dickinson), as the percentage of maximal cell lysis
obtained after addition of 0.2% (w/v) of Triton X-100, and as the mean þ S.D. of 4 independent experiments. Twenty combinations of the men-
tioned class S components together with one class F component (a : HlgB, b : LukD, E : LukF-PV, F : LukFP-PV) are presented.
Table 2
Time course of dermonecrotic reactions after the intradermal injections of doses of functional leucotoxins including either LukE, or LukD or
LukM proteins, and PVL as a reference [22]
Doses (ng) 100 300 1000 3000 10 000
Time (h) 12 24 48 12 24 48 12 24 48 12 24 48 12 24 48
LukE+LukD 2 2 2 3 4 4 3 5 5 4 5 5 4 5 5
LukE+LukF-PV 1 1 2 2 3 3 3 4 5 3 5 5 4 5 5
LukE+HlgB 1 1 1 1 2 1 2 3 3 2 3 3 3 3 3
LukE+LukFP-PV 1 2 2 2 4 4 3 4 5 3 5 5 4 5 5
LukM+LukFP-PV 1 1 2 1 2 2 2 3 4 2 4 4 2 4 4
LukM+LukD 1 1 1 2 2 2 3 4 4 3 4 4 4 4 4
LukM+LukF-PV 1 1 1 1 2 3 2 3 4 2 4 4 3 4 5
LukM+HlgB 1 1 0 1 1 1 1 2 1 1 3 3 2 3 3
LukS+LukD 1 1 1 1 1 1 1 2 3 2 4 4 2 4 4
PVL 1 2 2 3 4 4 3 4 5 4 5 5 4 5 5
LukS-PV+LukFP-PV 1 2 2 2 3 3 2 4 4 3 4 5 4 4 5
HlgA+LukD 1 1 1 1 2 2 1 3 3 3 4 5 4 5 5
HlgA+LukFP-PV 1 1 1 1 1 2 2 2 3 2 3 4 2 3 4
HlgC+LukD 1 2 0 2 2 1 2 2 3 3 4 4 3 4 4
HlgC+LukFP-PV 1 1 1 1 1 2 2 2 3 2 3 3 2 3 4
Scores were attributed as described in Section 2.
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reactions were always evolutive in the ¢rst 24 h, with slow
healing from 5 days to 2 weeks, as previously reported [9,24].
4. Discussion
The new leucotoxin LukE+LukD characterized in this work
remained undiscovered for two reasons. First, many of the
LukE+LukD-producing S. aureus strains are able to produce
simultaneously the Q-hemolysin whose components exhibit
similar molecular masses and which cannot be distinguished
by SDS-PAGE. The development of a de¢ned medium like
YCP medium was essential to determine the existence of
LukE+LukD (Fig. 1A). Second, despite a marked dermone-
crotic activity on rabbit skin, LukE+LukD is not strongly
hemolytic or leucotoxic on human blood cells, as currently
investigated for the other leucotoxins. HlgA+LukD was a
Ca2 channel inducer, whereas LukE+HlgB appeared only
working according to the donors (Table 1). These observa-
tions suggest either di¡erent cell receptors or di¡erent ways
in the processes of oligomerization for bi-component leuco-
toxins. Study of their binding sites should discard one of these
hypotheses.
Partial antigenic communities between class S and class F
proteins (Fig. 1B) and sequence identities of LukE/LukD with
the other bi-component leucotoxins indicate that it belongs to
this family of toxins. The 30% distribution of clinical strains
of S. aureus producing LukE+LukD was signi¢cantly di¡er-
ent (P6 0.005) from those of PVL- and Q-hemolysin pro-
ducers [8,21].
Staphylococcal K-toxin and bi-component leucotoxins were
suggested to possess similar structures allowing pore forma-
tion, especially for the rim and for the transmembrane stem
(residues 100^150 of LukE, LukD) domains [11,26]. However,
these toxins have functional di¡erences. Class S components
bind ¢rst to membrane ligands followed by secondary binding
of class F components [5,19,20]. Privileged cell targeting is
observed for PVL only active on cells derived from the meta-
myelocyte [10], whereas HlgA+HlgB and other leucotoxins
[24] are more or less active on both PMNs and erythrocytes,
or may permeate synthetic membranes [20]. K-Toxin is known
to be active upon erythrocytes, lymphocytes, keratinocytes
and ¢broblasts, but rather not on PMNs [1,3]. Thr30 of
HlgA and Thr28 of HlgC were important for the secondary
binding of class F proteins [20]. The two cited residues and
His35 from K-toxin also critical for its oligomerization
[3,11,26], may be aligned. Therefore, oligomerization of these
toxins may be mediated by di¡ering residue interactions. Bi-
component leucotoxins induce Ca2-channels [27], and form
pores sensitive to monovalent cations. Other pore-forming
toxins like K-toxin or aerolysin were not reported as calcium
inducers [1,3,17]. Na, K, and ethidium were exchanged
through the pores formed by leucotoxins [27], whereas those
formed by K-toxin [3] and aerolysin [1] excluded ethidium and
propidium.
Bi-component leucotoxins belong with K-toxin, aerolysin,
protective antigen of the anthrax toxin [17] to a super-family
of L-sheet structured pore-forming toxins. Those toxins pre-
viously named synergohymenotropic toxins [28] should be re-
called bi-component leucotoxins because they di¡er from tox-
ins as A/B bacteriocins and diphtheria toxin that acquire their
biological activity by a synergy with membranes.
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